Brief Introduction on China Horse Chestnut Extract Market
date：2010-07-23
browse：（385）
Keyword：
Aescin is the principal active ingredient of horse chestnut extract.Which was introduced to the herbal extract industry from the pharmaceutical sector by Xi'an Tiancheng as early as 2000.There are no more than five manfacturers supplying 20% horse chestnut extract(UV) in China.
According to herbridge.com,sodium aescinate was first developed as API.Horse chestnut line was avaiable after 2000 in China.According to Baoji Runyu Bio-technology Co.,Ltd,"Currently,15-20 ton of 20% aescin(UV) is for export every year.The international demand is increasing year by year.20% aescin(UV) is primarily used in health product industry.While the high content version is for cosmetic application. "
20% aescin(UV) is the common version in China herbal extract industry.The process is simple.A few manufacturers can supply this product,including Shaanxi Jiahe Phytochem Co.,Ltd
,Xi’an Origin Herb tech Co., Ltd,Xi’an Guanyu Bio-tech Co. Ltd..The process of 20% aescin(HPLC)is much more complicated.Moreover,some manufacturers in Shaanxi province don't want to study technique,neither do they diligently investigate the resources.It is not difficult to understand that very few manufacturers are supplying this product.With great technological advantage,Baoji Runyu is specilized in developing horse chestnut line.The company develops sodium aescinate at first.The complete line includes 20%,40% aescin(UV),20% aescin(HPLC),98% aescin(HPLC),B-aescin,aescinate polysulfonate.
Horse chestnut extract is derived from seeds of Aesculus chinensis.Which wildly grows in Yunnan ,Gansu,Jiangsu,Zhejiang,Qinling area.But only 100-120 tons of Aesculus chinensis can used as medicinal raw material.The herbal extract industry competes with the pharma industry to purchase raw materials,which to some extent stunts the former development.
According to herbridge.com,sodium aescinate was first developed as API.Horse chestnut line was avaiable after 2000 in China.According to Baoji Runyu Bio-technology Co.,Ltd,"Currently,15-20 ton of 20% aescin(UV) is for export every year.The international demand is increasing year by year.20% aescin(UV) is primarily used in health product industry.While the high content version is for cosmetic application. "
20% aescin(UV) is the common version in China herbal extract industry.The process is simple.A few manufacturers can supply this product,including Shaanxi Jiahe Phytochem Co.,Ltd
,Xi’an Origin Herb tech Co., Ltd,Xi’an Guanyu Bio-tech Co. Ltd..The process of 20% aescin(HPLC)is much more complicated.Moreover,some manufacturers in Shaanxi province don't want to study technique,neither do they diligently investigate the resources.It is not difficult to understand that very few manufacturers are supplying this product.With great technological advantage,Baoji Runyu is specilized in developing horse chestnut line.The company develops sodium aescinate at first.The complete line includes 20%,40% aescin(UV),20% aescin(HPLC),98% aescin(HPLC),B-aescin,aescinate polysulfonate.
Horse chestnut extract is derived from seeds of Aesculus chinensis.Which wildly grows in Yunnan ,Gansu,Jiangsu,Zhejiang,Qinling area.But only 100-120 tons of Aesculus chinensis can used as medicinal raw material.The herbal extract industry competes with the pharma industry to purchase raw materials,which to some extent stunts the former development.
The latest article
- White Paper on Bone and Joint Health of Chinese Consumers 2020
- Yili Dairy launched high-protein yogurt, focusing on sport people
- Sinopharm Xingsha launched the Japan's Champion probiotics
- China has introduced its first policy to support the industrial hemp industry
- Beyond Meat became the first overseas Artificial Meat company to set up a factory in China
- Nongfu Spring's market value exceeded HK $370 billion on its first day
- German infant nutrition brand Amykon launched two probiotics in China
- The revenue of Besunyoung in the first half year is about 610 million yuan
- Jellly candy and powder included in the health food filing dosage form in China
- H&H Group net profit increased by 9% for the first half of year
